Wilmington, DE -- (SBWIRE) -- 01/29/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Google Inc. (NASDAQ:GOOG) and Aratana Therapeutics, Inc. (NASDAQ:PETX).
Google Inc. (NASDAQ:GOOG) a technology company that builds products and provides services to organize the information and make it universally accessible and useful is currently down (-1.03%) on 878,127 shares traded as Google at Critical Moment in 3-Year Antitrust Probe, EU Said. Google Inc. (NASDAQ:GOOG) is currently down (-5.05%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Google Inc. (NASDAQ:GOOG)
Aratana Therapeutics, Inc. (NASDAQ:PETX) a development-stage biopharmaceutical company that focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe is currently up (+1.92%) on 2,618,086 shares traded after Aratana Therapeutics, Inc. Announced Upsizing and Pricing of Public Offering. Aratana Therapeutics, Inc. (NASDAQ:PETX) is currently up (+201.83%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Aratana Therapeutics, Inc. (NASDAQ:PETX)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report